UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
INSIGHTS & ANALYSIS

Industry Intelligence

Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation

Pharmaceutical7 October 2025· 12 min read

Frequency density safeguards statistical integrity in pharmaceutical and medical research 

A single figure can sway a submission or a clinical decision. When continuous data are grouped with unequal intervals, a simple count by bin exaggerates wide ranges and hides concentrated patterns. Th

By Priya Raghavan, Biotech & Markets Analyst

Research26 September 2025· 15 min read

Huntington's disease in the AI era evaluates cure claims and regulatory reality in 2025

Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research24 September 2025· 10 min read

Pivmecillinam naming branding and safety are explained clearly

A familiar antibiotic has crossed an ocean with an unfamiliar name. In April 2024 the U.S. Food and Drug Administration approved Pivya pivmecillinam for uncomplicated urinary tract infection in adult

By Dr. Eleanor Vance, Regulatory Affairs Editor

Treatments19 September 2025· 14 min read

Testosterone replacement therapy in the UK 2025 evidence based guidance for healthcare professionals

Testosterone replacement therapy is widely requested, yet appropriate use depends on accurate diagnosis. True androgen deficiency is a clinical and biochemical syndrome. Symptoms must align with repea

By Tom Okafor, Clinical Trials Correspondent

Research17 September 2025· 13 min read

Long COVID in 2025 reviews pathophysiology clinical management and the pharmacist role

Five years after the acute waves of COVID-19, Long COVID has settled into public health planning as a common post-infectious condition with sustained clinical, economic and social effects. The term de

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research10 September 2025· 11 min read

Nitazenes present an emerging synthetic opioid threat for healthcare professionals

Nitazenes are highly potent synthetic opioids from the benzimidazole family that now present a fast-moving threat in the United Kingdom and in other regions. The core scaffold places them apart from n

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research3 September 2025· 10 min read

An evidence based investigation into why people discontinue nicotinamide mononucleotide supplementation

Public attention to nicotinamide mononucleotide has grown quickly as evidence about NAD+ biology has entered mainstream discussion. Early animal data suggested broad benefits across metabolic and vasc

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research28 August 2025· 8 min read

Cellular rejuvenation and tissue repair

Cellular ageing is not a single event but a convergence of gradual molecular failures that accumulate over time. The recognised hallmarks include telomere attrition, genomic instability from DNA damag

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research7 August 2025· 13 min read

Molecular Biology in Pharmaceutical Science and Practice

Molecular biology studies how DNA, RNA and proteins control the behaviour of cells. It asks how genetic information is stored, copied, transcribed and translated, then traces how those molecular instr

By Dr. Eleanor Vance, Regulatory Affairs Editor

Treatments4 August 2025· 17 min read

What Is ERP Therapy? Understanding Exposure and Response Prevention in Mental Health Treatment

Exposure and Response Prevention (ERP) sits at the centre of modern, evidence-based care for obsessive and anxiety-driven conditions. It is a structured behavioural method that asks people to face wha

By Tom Okafor, Clinical Trials Correspondent

Research31 July 2025· 8 min read

CAR T‑cell Therapy Revolutionises Cancer Treatment

The idea that a single infusion of a patient's own immune cells could clear aggressive cancer once seemed like daring fiction. CAR T‑cell therapy has turned that notion into clinical fact, standing sh

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research25 July 2025· 8 min read

Hormone Replacement Therapy in Modern Clinical Practice

The hot flush that wakes you at 03:00, the sudden fog that steals a board‑room sentence, the invisible shift that hollows bones – the menopausal transition is blunt. Yet for many, relief sits in plain

By Dr. Eleanor Vance, Regulatory Affairs Editor

Stay ahead of the curve

Subscribe to our weekly pharmaceutical intelligence digest

Browse

Popular Categories in Pharma Journal

OncologyBiotechnologyPharmaceutical CompaniesClinical ResearchRegulatory, Quality & ComplianceMedical Devices, Diagnostics & EquipmentImmunology & Inflammation
Neuroscience & CNSInfectious Disease & VaccinesRare DiseasesAnimal & Veterinary HealthIndustry Media & AssociationsCell & Gene TherapyDermatology & Aesthetics
Genomics & Precision MedicineRespiratoryCardiovascular & MetabolicContract ManufacturingConsulting, Advisory & MedCommsHaematologyOphthalmology
Private Medical Clinics (London)Recruitment & TalentDigital Health & AIFertility & IVFLab, Reagents & Research ToolsMedical & Health InsuranceWomen's Health

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy